A larger cohort of liver samples from patients with MASLD (see Table S1) was analyzed for the mRNA expression of genes involved in APP and Aß-42 processing via non-amyloidogenic and amyloidogenic pathways. The gene discussed is APP; the disease is metabolic dysfunction-associated steatotic liver disease.